Exo70 Promotes the Invasion of Pancreatic Cancer Cells Via the Regulation of Exosomes

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Jan 23

PMID 38254825

Authors

Jingzhou Xiang

Bowen Zheng

Lingying Zhao

Yuting He

Fanzhuoran Lou

Runyang Li

Miao Fu

Xintian Huang

Wenqing Zhang

Xiaoting Hong

Li Xiao

Tianhui Hu

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer (PC) is an aggressive and fatal malignant tumor, and exosomes have been reported to be closely related to PC invasion and metastasis. Here we found that Exo70, a key subunit of the exocyst complex, promoted PC metastasis by regulating the secretion of tumor exosomes. Clinical sample studies showed that Exo70 was highly expressed in PC and negatively correlated with patients' survival. Exo70 promoted PC cell lines' invasion and migration. Interestingly, knockdown of Exo70, or using an Exo70 inhibitor (ES2) inhibited the secretion of tumor exosomes and increased the accumulation of cellular vesicles. Furthermore, Exo70 was found to accumulate in the exosomes, which then fused with neighboring PC cells and promoted their invasion. Moreover, Exo70 increased the expression of exosomal PD-L1, leading to the immune escape of PC cells. In vivo, knockdown of Exo70 or treatment with ES2 both decreased the tumor metastasis of PC cells in mice. This study provides new insight into the mechanism of invasion and metastasis in PC and identifies Exo70 as a potential prognostic factor and therapeutic target for PC.

Citing Articles

Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics.

Ye Z, Li G, Lei J Exp Mol Med. 2024; 56(11):2365-2381.

PMID: 39528800 PMC: 11612210. DOI: 10.1038/s12276-024-01340-w.

The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy.

Qin C, Li T, Lin C, Zhao B, Li Z, Zhao Y Cancer Cell Int. 2024; 24(1):264.

PMID: 39054529 PMC: 11271018. DOI: 10.1186/s12935-024-03456-5.

References

Topalian S, Taube J, Anders R, Pardoll D . Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016; 16(5):275-87. PMC: 5381938. DOI: 10.1038/nrc.2016.36. View

Han Q, Li W, Hu K, Gao J, Zhai W, Yang J . Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022; 21(1):207. PMC: 9623991. DOI: 10.1186/s12943-022-01671-0. View

Yu D, Li Y, Wang M, Gu J, Xu W, Cai H . Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022; 21(1):56. PMC: 8855550. DOI: 10.1186/s12943-022-01509-9. View

Kalluri R, LeBleu V . The biology function and biomedical applications of exosomes. Science. 2020; 367(6478). PMC: 7717626. DOI: 10.1126/science.aau6977. View

van Niel G, DAngelo G, Raposo G . Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19(4):213-228. DOI: 10.1038/nrm.2017.125. View

He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X . Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Lett. 2022; 548:215751. DOI: 10.1016/j.canlet.2022.215751. View

Shen Y, Xue C, Li X, Ba L, Gu J, Sun Z . Effects of Gastric Cancer Cell-Derived Exosomes on the Immune Regulation of Mesenchymal Stem Cells by the NF-kB Signaling Pathway. Stem Cells Dev. 2019; 28(7):464-476. DOI: 10.1089/scd.2018.0125. View

Linton S, Abraham T, Liao J, Clawson G, Butler P, Fox T . Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. PLoS One. 2018; 13(11):e0206759. PMC: 6211741. DOI: 10.1371/journal.pone.0206759. View

Zhao Y, Hong X, Chen X, Hu C, Lu W, Xie B . Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux. Cancers (Basel). 2021; 13(14). PMC: 8304026. DOI: 10.3390/cancers13143467. View

10.

Mao L, Zhan Y, Wu B, Yu Q, Xu L, Hong X . ULK1 phosphorylates Exo70 to suppress breast cancer metastasis. Nat Commun. 2020; 11(1):117. PMC: 6949295. DOI: 10.1038/s41467-019-13923-7. View

11.

Mei K, Guo W . The exocyst complex. Curr Biol. 2018; 28(17):R922-R925. DOI: 10.1016/j.cub.2018.06.042. View

12.

Poggio M, Hu T, Pai C, Chu B, Belair C, Chang A . Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Cell. 2019; 177(2):414-427.e13. PMC: 6499401. DOI: 10.1016/j.cell.2019.02.016. View

13.

Martin-Urdiroz M, Deeks M, Horton C, Dawe H, Jourdain I . The Exocyst Complex in Health and Disease. Front Cell Dev Biol. 2016; 4:24. PMC: 4828438. DOI: 10.3389/fcell.2016.00024. View

14.

Henriksen A, Dyhl-Polk A, Chen I, Nielsen D . Checkpoint inhibitors in pancreatic cancer. Cancer Treat Rev. 2019; 78:17-30. DOI: 10.1016/j.ctrv.2019.06.005. View

15.

Xie Z, Gao Y, Ho C, Li L, Jin C, Wang X . Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2021; 71(3):568-579. DOI: 10.1136/gutjnl-2020-323014. View

16.

Lu H, Liu S, Zhang G, Kwong L, Zhu Y, Miller J . Oncogenic BRAF-Mediated Melanoma Cell Invasion. Cell Rep. 2016; 15(9):2012-24. PMC: 4889462. DOI: 10.1016/j.celrep.2016.04.073. View

17.

Cai J, Chen H, Lu M, Zhang Y, Lu B, You L . Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021; 520:1-11. DOI: 10.1016/j.canlet.2021.06.027. View

18.

Chen G, Huang A, Zhang W, Zhang G, Wu M, Xu W . Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560(7718):382-386. PMC: 6095740. DOI: 10.1038/s41586-018-0392-8. View

19.

Moore A, Donahue T . Pancreatic Cancer. JAMA. 2019; 322(14):1426. PMC: 7021307. DOI: 10.1001/jama.2019.14699. View

20.

Liu J, Zhao Y, Sun Y, He B, Yang C, Svitkina T . Exo70 stimulates the Arp2/3 complex for lamellipodia formation and directional cell migration. Curr Biol. 2012; 22(16):1510-5. PMC: 3427469. DOI: 10.1016/j.cub.2012.05.055. View